|
Model Number ATL2001 |
Device Problem
Material Deformation (2976)
|
Patient Problems
Hemorrhage/Bleeding (1888); No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 06/22/2020 |
Event Type
Injury
|
Event Description
|
Medtronic received information that during use of a wash kit atl2001, the consumables violently vibrated during high-speed operation and could not work normally.To avoid damage to the patient's blood components, the anesthesiologist immediately halted the machine and replaced the consumables to complete the procedure.The blood volume required replenishment.There was no adverse effect on the patient reported.
|
|
Manufacturer Narrative
|
Conclusion: no root causes were confirmed as a result of this investigation.During the process review it was confirmed that the man ufacturing process is running according to procedure.The failure mode reported (blood leak) is already considered in the risk document where the controls stablished are still operating on the production line (leak test 100%), the leak tester, and the welding equi pment for the bowl assembly were confirmed under the calibration requirements during dhr review.Functional testing performed by quality inspectors to assembled bowls have been accepted during the last 3 months with no leaks, noises, vibration, fin damage, errors or failures reported.No anomalies were found during dhr review either.The affected product could not be analyzed at design site.It is considered that the failure could be related to the presence of a clot during the process.The clot could not allow fluid flow and the kit could not be able to perform the blood collection.The disposable can not cause or prevent clotting.It is very important to add sufficient anticoagulant volumes and re-priming the collection reservoir every time that it is emptied.No more information for the case could be provided.According to the evidence collected during investigation the root cause cannot be confirmed or attributed to the manufacturing process of the product.Actions for the manufacturing site will not be established since there is no evidence that the reported complaint was originated by the manufacturing at medtronic.This regulatory report is being submitted as part of a retrospective review and remediation per (b)(4) as part of a capa action.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Correction b1: updated to adverse event <(>&<)> product problem correction b2: updated to intervention required correction h6: ime/annex e and imf/annex f updated medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|